logo
Yunu Unveils Next-Gen Trial Imaging with New eCRF Builder, Custom Dashboards & Universal Integration Portal

Yunu Unveils Next-Gen Trial Imaging with New eCRF Builder, Custom Dashboards & Universal Integration Portal

Miami Herald29-05-2025
CARY, NC / ACCESS Newswire / May 29, 2025 / Yunu, the creator and leader in cloud-native imaging workflows for clinical trials, today announced a major new software release that empowers pharma sponsors to configure studies in minutes, enforce consistency, and deliver imaging data straight into their primary data systems - while simplifying work for site staff.
Yunu's unified cloud-SaaS platform powers end-to-end imaging workflows for thousands of clinical trials worldwide. From de-identification and site assessments to blinded reads with adjudication and real-time data delivery to sponsors, Yunu harmonizes multi-site trials, reduces complexity, and accelerates timelines, thereby reducing costs for both sponsors and sites. Expanding these capabilities, Yunu's new eCRF builder, enhanced sponsor dashboards, and native integration portal deliver a new realm of possibilities for trial sponsors who have previously been limited to inefficient and expensive manual workflows, long timelines, and disconnected data.
"To deliver better outcomes for patients, we have to be more protective of the imaging data that will define tomorrow's treatments," said Jeff Sorenson, CEO & Co-founder of Yunu. "With our new eCRF builder, intuitive dashboards, and seamless integration portal, sponsors gain full control over imaging endpoints - while sites benefit from a simpler, guided workflow and access to expert reading resources."
KEY SPONSOR BENEFITS
Rapid Customization of Imaging eCRFsProvides flexible capture of trial-specific data from directly within the QC and reading process, easily defined during the 30-minute study setup process, with no coding or delays.Real-Time Data, Custom Dashboards1,300+ standard data elements deliver unmatched context, traceability, and value with active monitoring of imaging schedules, scan availability, read status, and response rates across any combination of trials, therapeutic areas, participating sites, or endpoints.Seamless Data IntegrationThe Yunu integration portal supports user-defined and configured APIs, allowing for easy integration between other eClinical and data systems and your Yunu imaging source of truth. Imaging eCRF outputs and all other captured data are sent directly from Yunu into your clinical data warehouse or EDC system in real time - eliminating manual handoffs and file transfers.
SITE ADVANTAGES
Guided, Error-Free WorkflowsRadiologists, whether onsite or remote, follow the same step-by-step process, delivering complete, standardized, harmonized, protocol-conformant imaging endpoints that eliminate cumbersome and error-prone manual paper forms or spreadsheets.Faster Read TurnaroundBy streamlining end-to-end imaging workflows and data management tasks, Yunu frees up site staff to focus on patient care rather than paperwork.
All new features are available immediately to every Yunu customer and may be activated on any new or ongoing trial. Yunu will be exhibiting at the American Society of Clinical Oncology's (ASCO) Annual Meeting this weekend from Saturday, May 31st - Monday, June 2nd, at Booth #10080. Visit Yunu at ASCO or connect with the team by visiting yunu.io/contact-us.
ABOUT YUNUYunu enables life sciences organizations to streamline imaging workflows, improve accuracy, and accelerate timelines. Yunu's platform supports clinical trials across various therapeutic areas, offering scalability and flexibility for organizations of all sizes. For more information, visit yunu.io and follow us on LinkedIn or X @Yunu_Inc.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

CannaPharmaRX Expands Cannabis Exports, Projects $1M+ Q3 Revenue
CannaPharmaRX Expands Cannabis Exports, Projects $1M+ Q3 Revenue

Associated Press

time2 hours ago

  • Associated Press

CannaPharmaRX Expands Cannabis Exports, Projects $1M+ Q3 Revenue

CREMONA, AB / ACCESS Newswire / August 19, 2025 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an emerging leader in global cannabis cultivation and exports, announces a series of strategic developments. The goal is to strengthen its international footprint and production capacity. The company continues to make significant steps in its mission to supply premium cannabis products to high-demand international markets, including Germany, Portugal, and Israel. Here's an overview of their recent shipments along with the Q3 revenue estimate. Major Cannabis Shipments to Europe Building on its successful export operations, CannaPharmaRX has completed its second shipment to Germany in July by delivering 139.6 kilograms. Demand remains strong in Germany for our product, and we continue to take new orders for our strains. In August, the company plans to execute two additional shipments to Germany and Portugal totaling 300 kilograms: ● 180.2 kg of high-THC products marking continued interest in our premium products. ● 119.8 kg of low-THC products for the more economical strains that we are producing. Expanding Presence in Israel In addition to its European exports, CannaPharmaRX is also preparing a shipment of approximately 142 kg of medium-quality cannabis buds to Israel. This is another step in the company's strategy to diversify its customer base and strengthen trade relationships in international markets. We are deliberately growing strains that cater to different consumers and different pricing needs so that we are scaling across all sectors. Scaling Up Production with a New Growing Room To meet increasing demand, CannaPharmaRX plans to open its sixth growing room in September, bringing it closer to its total capacity of ten potential grow rooms. The expansion will also allow the company to cultivate new, recently tested cannabis varieties that have delivered promising results during trials. Strong Q3 Revenue Forecast The company projects third-quarter revenues of approximately $1,050,000 CAD, with the anticipation of additional shipments before the end of September. This forecast may vary slightly depending on fluctuations in the Euro-to-Canadian Dollar exchange rate. CTO Update CannaPharmaRX continues to address regulatory matters in Canada with the BCSC. The company will submit a detailed response to the latest communication received in May by the end of August, with legal guidance from Fasken Law Firm. Contact: Company: CannapharmaRx Name: Constantine Nkafu Website: Phone: 403-637-0420 Mail: [email protected] SOURCE: CannaPharmaRx press release

The Assistance Fund Opens New Program for Bronchiectasis
The Assistance Fund Opens New Program for Bronchiectasis

Associated Press

timea day ago

  • Associated Press

The Assistance Fund Opens New Program for Bronchiectasis

Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Bronchiectasis ORLANDO, FL / ACCESS Newswire / August 18, 2025 / The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new copay assistance program for people living with bronchiectasis. The program is designed to help eligible individuals pay for their out-of-pocket medical costs for treatment, such as copays, coinsurance, and deductibles. Bronchiectasis is a chronic lung disease where people are unable to properly clear mucus. People living with bronchiectasis experience a buildup of mucus in the lungs that can cause infections and coughing fits. Nearly half a million Americans currently live with bronchiectasis. [1] 'Living with bronchiectasis means more than managing a chronic lung condition-it involves unpredictable flare-ups, ongoing treatment, and the financial strain of affording those costs,' said Danielle Vizcaino, President and CEO of The Assistance Fund. 'Thanks to our generous donors, our Bronchiectasis Copay Assistance Program helps ease that burden, allowing people to focus on their health rather than the next medical bill.' To learn more or determine eligibility for financial support, visit or call (833) 426-2085 to speak with a Patient Advocate. A list of all the disease programs available from The Assistance Fund can be found on the website About The Assistance Fund The Assistance Fund (TAF) is an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance, deductibles, and other health-related expenses. The Assistance Fund currently manages nearly 100 disease programs, each of which covers all the FDA-approved medications that treat a specific disease named in the disease program. Since its founding in 2009, TAF has helped over 210,000 children and adults access the treatment they need to stay healthy or manage a life-changing disease. To learn more about The Assistance Fund, or for information on how to donate, please visit Media Contact Margaret Figley Senior Director of Communications [email protected] [1] Cleveland Clinic, 'Bronchiectasis,' accessed August 2025. SOURCE: The Assistance Fund (TAF) press release

Australia's Top Healthcare IT Vendors Named by Black Book Research in 2025 Annual User Rankings
Australia's Top Healthcare IT Vendors Named by Black Book Research in 2025 Annual User Rankings

Associated Press

timea day ago

  • Associated Press

Australia's Top Healthcare IT Vendors Named by Black Book Research in 2025 Annual User Rankings

Live results announced today in Melbourne at HIC 2025, Australia's largest digital health and health informatics industry gathering MELBOURNE, AU / ACCESS Newswire / August 18, 2025 / Black Book Research today announced the 2025 top-rated healthcare IT vendors in Australia, recognizing leaders across 13 categories of digital health and hospital information systems. The results were unveiled live at the HIC 2025 conference and on the event website, as more than 1,500 healthcare leaders, clinicians, and technology suppliers gather at the Melbourne Convention and Exhibition Centre. The annual survey drew 864 validated responses from executives, clinicians, and IT leaders across 520 public and 344 private hospitals, representing a broad spectrum of Australia's health sector. Vendors were rated across 18 performance indicators. 2025 Top Vendors by Category - Australia Key Findings Australia's Public hospitals ranked Oracle Health, InterSystems, and Microsoft Azure highest for scalability and alignment with national digital health standards. Private hospitals favored Personify Care, CareMonitor, and Episoft for measurable ROI and Australian-focused patient experience improvement. Solventum earned top marks in coding and HIM, reflecting adoption of analytics and automated coding solutions. Salesforce was recognized for leadership in patient relationship management, supporting health cloud and CRM-driven engagement models. Hyland achieved top ratings in enterprise content and document management, particularly in imaging workflows and secure health records. Australian innovators Heidi Health, DC2Vue, and CareMonitor were noted for agility and responsiveness to evolving government digital health priorities. Australian Health IT Trends (Q2-Q3 2025 Update) From the flash survey in July and August 2025, 484 responses by Australian HIT professionals several trends emerged: Survey Confidence & Methodology With 864 hospitals responding, the survey sample represents two-thirds of all Australian inpatient healthcare facilities, providing a 95% confidence level with a margin of error under 3% for national benchmarking. The 2025 Australian Health Information Systems and Digital Health Survey assessed vendor performance across 18 KPIs, including compliance with Australian regulations, interoperability with My Health Record, cybersecurity and uptime, cloud sovereignty and data residency, clinical usability, ROI, sustainability, implementation support, telehealth capabilities, patient engagement outcomes, and delivery integrity. KPIs were weighted by hospital type and vendor category to reflect real-world priorities, ensuring comparability and accuracy. Access the Full Global HIT Report A complimentary copy of the 530-page 2025 Black Book of Global Healthcare IT, including Q3 updates, is available for download at: For additional data or media inquiries, contact: [email protected] or visit About Black Book Research Black Book Research is an independent global healthcare IT benchmarking firm. The company provides impartial, crowd-sourced vendor evaluations free from financial influences, helping hospitals, payers, and governments worldwide make informed technology decisions. Contact InformationPress Office 8008637590 SOURCE: Black Book Research press release

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store